Surfactant apoprotein-A concentration in airway secretions for the detection of pulmonary oedema

European Respiratory Journal

Volumn 9, Issue 12, 1996, Pages 2525-2530

  Shimura, S ^a,b   Masuda, T ^a   Takishima, T ^a   Shirato, K ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

airway secretion; pulmonary oedema; sputum; surfactant apoprotein A

Indexed keywords

APOLIPOPROTEIN A;

ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; LUNG EDEMA; MALE; PRIORITY JOURNAL; SPUTUM ANALYSIS;

EID: 0029989431     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.96.09122525     Document Type: Article

References (23)

1. King RJ, Clements JA. Surface active materials from dog lung. II. Composition and physiological correlations. Am J Physiol 1972; 223: 715-726.
2. Young SL, Wright JR. Clements JA. Cellular uptake and processing of surfactant lipids and apoproteins SP-A by rat lung. J Appl Physiol 1989; 66: 1336-1342.
3. Kuroki Y, Fukuda Y, Takahashi H, Akino T. Monoclonal antibodies against human pulmonary surfactant apoproteins: specificity and application in immunoassay. Biochim Biophys Acta 1985; 836: 201-209.
4. Kuroki Y, Takahashi H, Fukada Y, et al. Two-site "simultaneous immunoassay" with monoclonal antibodies for the determination of surfactant apoproteins in human amniotic fluid. Pediatr Res 1985; 19: 1017-1020.
5. Snyder JM, Kwun JE, O'Brien JA, Rosenfeld CR, Odom MJ. The concentration of the 35 kDa surfactant apoprotein in amniotic fluid from normal and diabetic pregnancies. Pediatr Res 1988; 24: 728-734.
6. Akino T, Shimizu H, Mizumoto M, et al. Simplified monoclonal immunoassay for pulmonary surfactant 35 kDa apoprotein in human amniotic fluid. Clin Chem 1989; 34: 1513.
7. Shimizu H, Hosoda K, Mizumoto M, et al. Improved immunoassay for the determination of surfactant protein A (SP-A) in human amniotic fluid. Tohoku J Exp Med 1989; 157: 269-278.
8. Masuda T, Shimura S, Sasaki H, Takishima T. Surfactant apoprotein A concentration in sputum for diagnosis of pulmonary proteinosis. Lancet 1991; 337: 580-582.
9. Chakko S, Woska D, Martienz H, et al. Clinical, radiographic and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care. Am J Med 1991; 90: 353-359.
10. Swan HJC, Ganz W, Forrester J, Marcus H, Diamond G, Chonette D. Catheterization of the heart in man with use of a flow-directed balloon-tipped catheter. N Engl J Med 1970; 283: 447-451.
11. Mermel LA, Maki DC. Infectious complications of Swan-Ganz pulmonary artery catheters: pathogensis, epidemiology, prevention, and management. Am J Respir Crit Care Med 1994; 149: 1020-1036.
12. Fowler A, Hamman R, Zerbe G, Benson K, Hyers T. Adult respiratory distress syndrome: prognosis after onset. Am Rev Respir Dis 1985; 132: 472-478.
13. Kuroki Y, Tsutahara S, Shijubo N, et al. Elevated levels of lung surfactant protein A in sera from patients with pulmonary fibrosis and pulmonary alveolar proteinosis. Am Rev Respir Dis 1993; 147: 723-729.
14. Crapo ID. New concepts in the formation of pulmonary edema. Am Rev Respir Dis 1993; 147: 790-792.
15. Bachofen H, Schüren S, Weibel ER. Experimental hydrostatic pulmonary edema in rabbit lungs: barrier lesions. Am Rev Respir Dis 1994; 147: 997-1004.
16. Masuda T, Shimura S, Takishima T. Surfactant apoprotein A in airway secretions in pulmonary oedema (Letter). Lancet 1991; 338: 1396-1397.
17. Hasegawa N, Husari AW, Hart WT, Kandra TG, Raffin TA. Role of the coagulation system in ARDS. Chest 1994; 105: 268-277.
18. Holm BA, Venkitaraman AR, Enhorning G, Notter RH. Biophysical inhibition of synthetic lung surfactants. Chem Phys Lipids 1990; 52: 243-250.
19. Baughman RP, Stemberg RI, Hull W, Buchsbaum JA, Whitsett I. Decreased surfactant protein A in patients with bacterial pneumonia. Am Rev Respir Dis 1993; 147: 653-657.
20. Gregory TJ, Longmore WJ, Moxley MA, et al. Surfactant chemical composition and biophysical activity in adult respiratory distress syndrome. J Clin Invest 1991; 88: 1976-1981.
21. Pison U, Obertacke U, Seeger W, Hawgood S. Surfactant protein A (SP-A) is decreased in acute parenchymal lung injuries associated with polytrauma. Eur J Clin Invest 1992; 22: 712-728.
22. Doyle IR, Nicholas TE, Bersten AD. Serum surfactant protein-A levels in patients with acute cardiogenic pulmonary edema and adult respiratory distress syndrome. Am J Respir Crit Care Med 1995; 152: 307-317.
23. Batenburg JJ, Elfring RH. Pretranslational regulation by glucocorticoid of fatty acid and phosphatidylcholine synthesis in type II cells from fetal rat lung. FEBS Lett 1992; 307: 164-168.